Optimal glycemic control is associated with a lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous coronary intervention.
about
Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitusTargeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitusTargeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitusNeointimal hyperplasia persists at six months after sirolimus-eluting stent implantation in diabetic porcineVessel shrinkage as a sign of atherosclerosis progression in type 2 diabetes: a serial intravascular ultrasound analysisPeriprocedural glycemic control in patients with diabetes mellitus undergoing coronary angiography with possible percutaneous coronary intervention.The basic social medical insurance is associated with clinical outcomes in the patients with ST-elevation myocardial infarction: a retrospective study from Shanghai, ChinaIntensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trialsRevascularization for coronary artery disease in diabetes mellitus: angioplasty, stents and coronary artery bypass grafting.The association of diabetes mellitus with clinical outcomes after coronary stenting: a meta-analysis.Platelet function in patients with diabetes mellitus: from a theoretical to a practical perspectiveAssociation of elevated fasting glucose with lower patency and increased major adverse limb events among patients with diabetes undergoing infrapopliteal balloon angioplasty.Impact of glycaemic and lipid control on outcome after percutaneous coronary interventions in diabetic patients.Percutaneous coronary interventions with drug eluting stents for diabetic patientsEfficacy of drug eluting stents in patients with and without diabetes mellitus: indirect comparison of controlled trials.Multiple predictors of coronary restenosis after drug-eluting stent implantation in patients with diabetesEvaluation of in-stent restenosis in the APPROACH trial (Assessment on the Prevention of Progression by Rosiglitazone On Atherosclerosis in diabetes patients with Cardiovascular History).Association Between Glycosylated Hemoglobin Level and Cardiovascular Outcomes in Diabetic Patients After Percutaneous Coronary Intervention.Percutaneous coronary revascularization in diabetics: from balloon angioplasty to drug-eluting stents.Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stenting.Contribution of aldose reductase to diabetic hyperproliferation of vascular smooth muscle cellsPeriprocedural management of the patient with diabetes mellitus undergoing coronary angiography: current practice.Gender differences in clinical outcomes among diabetic patients hospitalized for cardiovascular diseaseClinical and economic benefits associated with the achievement of both HbA1c and LDL cholesterol goals in veterans with type 2 diabetes.Percutaneous coronary intervention in diabetic patients: should choice of stents be influenced?The vascular smooth muscle cell: a therapeutic target in Type 2 diabetes?Drug-eluting stent outcomes in diabetes.Revascularization for Advanced Coronary Artery Disease in Type 2 Diabetic Patients: Choosing Wisely Between PCI and Surgery.Optimal choice of coronary revascularization and stent type in diabetic patients with coronary artery disease.Glycaemic control and restenosis after percutaneous coronary interventions in patients with diabetes mellitus: a report from the Insulin Diabetes Angioplasty study.Glycemic Control in Coronary Revascularization.Short term follow-up of prediabetics undergoing elective percutaneous coronary interventionEffect of normalization of fasting glucose by intensified insulin therapy and influence of eNOS polymorphisms on the incidence of restenosis after peripheral angioplasty in patients with type 2 diabetes: a randomized, open-label clinical trial.Does HbA1c Level Have Clinical Implications in Diabetic Patients Undergoing Coronary Artery Bypass Grafting? A Systematic Review and Meta-Analysis.Predictors of restenosis after percutaneous coronary intervention using bare-metal stents: a comparison between patients with and without dysglycemia.Impact of diabetes mellitus on long-term clinical outcomes of patients on chronic hemodialysis after percutaneous coronary intervention.Relationship between haemoglobin A1C values and recurrent cardiac events: A retrospective, longitudinal cohort study.Effect of Paclitaxel-eluting versus sirolimus-eluting stents on coronary restenosis in Korean diabetic patients.An increase in HbA1c after percutaneous coronary intervention raises the risk for restenosis in patients without Type 2 diabetes mellitus.Current concepts on coronary revascularization using BRS in patients with diabetes and small vessels disease.
P2860
Q24186667-5A906434-C1DB-4E0B-BF4C-E5E277399945Q24202505-F8B6DEA4-BCDB-4979-BB90-6B3224B290EFQ24236456-C30358BE-56CE-423D-895A-FB6036C52CD5Q28212482-184941CD-A7E8-44F7-BF59-607AFEBDBD7CQ30484282-F83E889B-0B7A-46A9-82AE-4DF29CFA03B4Q33600990-AEC746A3-A29A-4336-879E-06ABC225C501Q33843868-3326CABF-147A-4FFB-A447-9C896B337DE2Q34083400-2462994C-BF85-4075-AA2E-DC6B0D622D66Q34793647-F8A4504E-A1DE-4968-8823-3D54D1E762A2Q34996907-120E5C93-257A-4FE7-B990-D94E64AD0C5FQ35174193-71496E55-FFCC-41AC-9213-5242EF0ECFC2Q35469793-7E9E5E3D-EC88-4A32-97FA-8699FAAE1387Q35583263-3BE78D12-DD7A-4F51-B980-ED309F5FA672Q35771445-9A547EFA-8AD1-43C8-B11F-D57DA4723A2CQ35771807-CAF70361-4B85-495C-B172-7DE25A1D53A1Q35772244-75EEE526-2698-45ED-99FC-A31CD0B69A78Q35888976-4D9DE8E6-A290-49E0-ADC0-168EB2DC527AQ36016740-CCC98CA8-8A0E-4562-8E3B-ED822BFA9406Q36216817-A0309BCC-D84A-4B6A-A740-47B57D77C86DQ36241566-E9AEA529-4D56-4467-9479-C4AA58E5D787Q36296605-4864B964-898A-43F0-8B01-A71DC92AC93CQ36621669-C50EA4AF-8D48-4C89-8C5A-1412D333DBD3Q36913858-041EE2C2-1AE5-46A7-BFEA-AE84ABD929DFQ37193496-2DFF6520-BD1F-4755-9EA7-4C5F225AA7DBQ38101961-6D450880-D5AC-4A63-A5D0-069E26350BB4Q38103313-418DA047-48CA-4457-AC98-1F6FBD9BD6C3Q38171868-FAFFFB37-998F-4706-BBF4-A76BCE7715C0Q38735428-8E33A1F2-0624-4F32-A248-CADE69D2662EQ39410697-D03D9D28-B984-4B31-A311-19CD81FCDA43Q39885755-F8B26917-6BA9-4AE0-9774-C6F2FE64E470Q40048851-BAD10F9C-D47F-43DB-B1EF-DB3DFE20157AQ40509667-D61F6EC0-784B-41BA-832C-90CF85156FD5Q42511510-6528D8AB-B15B-4FEB-825E-3AA4BE9A112DQ42718272-40570010-B70E-4ED4-A8F8-9E9E32167183Q43045641-421BA1FA-E4EA-4C4E-ADFD-CFBFFBD105AFQ44518607-869601A2-DA3B-482E-A3C3-0AFA3838CE48Q46504413-FF1F9D23-5E5B-4316-9CA5-C0F058F6E675Q46701610-7E0B2E72-9D06-43A1-99C7-A75FF881A9DDQ46889608-05E55009-C0F4-4435-A5A1-724B065AC731Q47999843-C000D543-DA2D-4CF7-99F9-9926EDCAA0DA
P2860
Optimal glycemic control is associated with a lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous coronary intervention.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Optimal glycemic control is as ...... taneous coronary intervention.
@en
Optimal glycemic control is as ...... taneous coronary intervention.
@nl
type
label
Optimal glycemic control is as ...... taneous coronary intervention.
@en
Optimal glycemic control is as ...... taneous coronary intervention.
@nl
prefLabel
Optimal glycemic control is as ...... taneous coronary intervention.
@en
Optimal glycemic control is as ...... taneous coronary intervention.
@nl
P2093
P1476
Optimal glycemic control is as ...... taneous coronary intervention.
@en
P2093
Gerald C Timmis
John A House
Mamtha Balasubramaniam
Peter B George
Roberto A Corpus
Simon R Dixon
Steven C Ajluni
William H Devlin
William W O'Neill
P356
10.1016/J.JACC.2003.06.019
P407
P577
2004-01-01T00:00:00Z